language_icon
EN
HI

Wockhardt Share price

WOCKPHARMA

1716.9

0.00 (0.00%)
NSE
BSE
Last updated on 6 May, 2026 | 15:59 IST
Today's High

1778.00

Today's Low

1558.60

52 Week Low

1086.70

52 Week High

1868.80

Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Wockhardt Chart

Wockhardt Share Key Metrics

Volume
2.30 CR
Market Cap
27898.28 CR
LTQ@LTP
50@1716.90
ATP
1715.26
Var Margin
24.83 %
Circuit Range
1373.6-2060.2
Delivery %
8.87 %
Value
3942.66 CR
ASM/GSM
No
Market Lot
1

Summary

Wockhardt share price stands at ₹1716.9 at 6 May, 2026 | 15:59. The stock Wockhardt intraday movement has stayed between ₹1558.60 and ₹1778.00, while on a 52-week basis it has fluctuated from ₹1086.70 to ₹1868.80.
In terms of trading activity, Wockhardt has recorded a volume of 22985789 shares. The Wockhardt has a market cap of ₹162492169. The stock’s Average Traded Price (ATP) stands at ₹171526, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 50, 171690.
The Wockhardt operates within a circuit range of ₹1373.6-2060.2 – ₹1373.6-2060.2, with a Value of ₹3942.66 CR. The Delivery Percentage for the day is 8.87%. Additionally, Wockhardt currently falls under the No framework, and trades with a market lot size of 1.

Wockhardt Fundamentals

View More
P/E Ratio

117.27

P/B Ratio

5.06

Div. Yield

0

Sector P/E

65.98

Sector P/B

3.52

Sec. Div. Yield

0.56

Wockhardt Resistance and Support

Pivot 1684.5

Resistance

First Resistance

1810.4

Second Resistance

1903.9

Third Resistance

2029.8

Support

First Support

1591

Second Support

1465.1

Third Support

1371.6

Wockhardt Shareholding Pattern

View More
  • 2016-17
  • 2018-19
  • 2019-20
  • 2020-21
  • 2021-22
  • 2022-23
  • 2023-24
  • 2024-25
  • 2025-26
  • 2026-27
Total Promoters
Segment
Percent

Total Promoters

49.08%

Mutual Fund

8.12%

Insurance

0.06%

Foreign Institutional Investors

7.08%

Domestic Institutional Investors

2.81%

Retail

32.84%

Others

0.01%

Total Promoters
MAR '26
49.08%

Wockhardt Corporate Actions

DateAgenda
2026-05-04Audited Results & Others
2026-02-10Quarterly Results
2025-11-03Quarterly Results
2025-08-08Quarterly Results
2025-05-29Audited Results & Fund Raising
2025-02-07Quarterly Results

Wockhardt News

Wockhardt shares jump 10% after profitability returns in Q4, margins expand on revenue growth

Wockhardt reported a significant financial turnaround in Q4 FY26, posting a consolidated net profit of ₹166 crore, reversing a net loss of ₹25 crore from the previous year. The company's revenue increased by 30% year-on-year to ₹965 crore, driven by robust growth in biotech operations and key markets, with EBITDA margins expanding to 20.3%.
May 05 2026 12:05:00

Wockhardt shares jump 9% after strong Q4 turnaround, robust FY26 growth

Wockhardt shares surged 9% following a strong turnaround in its March quarter performance. The company reported a positive net profit and substantial revenue growth, with full-year earnings also improving. Key drivers included biotech operations and expansion in emerging markets, alongside new product filings and approvals.
May 05 2026 09:05:00

Wockhardt Ltd - 532300 - Announcement under Regulation 30 (LODR)-Monitoring Agency Report

Wockhardt received a monitoring report from CRISIL for Q4 FY26 confirming no deviation in the utilization of QIP proceeds. However, Rs. 162.33 crore allocated for capital expenditure and R&D will now be utilized by FY2028, extending the original timeline.
May 04 2026 18:05:00

Wockhardt Limited

Wockhardt Limited has filed its Monitoring Agency Report for the Qualified Institutional Placement (QIP) proceeds utilization for the quarter ended March 31, 2026. The report confirms that there has been no deviation in the utilization of issue proceeds from the objects as stated in the Placement Document. Additionally, the utilization period for Rs 162.33 crore allocated for capital expenditure and R&D has been extended to FY2028.
May 04 2026 18:05:00

Wockhardt Ltd - 532300 - Announcement under Regulation 30 (LODR)-Change in Management

Wockhardt appointed three Senior Management Personnel, including a new President for India Business and two Senior Vice Presidents for Biotech and R&D, effective May 4, 2026. These appointments strengthen key leadership areas.
May 04 2026 18:05:00

Wockhardt Ltd - 532300 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Wockhardt announced its FY26 financial results, with PBT turning positive to Rs.238 Cr. The company also highlighted significant Q4FY26 revenue growth of 30% to Rs.965 Cr and several key product approvals and launches, including MIQNAF® in India.
May 04 2026 15:05:00

Wockhardt Ltd - 532300 - Board Meeting Outcome for Outcome Of The Board Meeting Held On 4Th May, 2026

Wockhardt's board approved FY26 consolidated revenue of ₹3,484 crore and net profit of ₹199 crore, marking a turnaround from a previous year's loss. They also approved a proposal to raise funds through equity or convertible securities, subject to shareholder approval at the AGM.
May 04 2026 15:05:00

Wockhardt Limited

Wockhardt board meeting scheduled for May 4, 2026, to approve audited annual standalone and consolidated financial results for FY26. The board will also consider proposals for fund raising, with the mode of raising funds yet to be ascertained.
Apr 28 2026 16:04:00

Wockhardt Limited

Wockhardt board meeting scheduled for May 4, 2026, to approve audited annual standalone and consolidated financial results for FY26. The board will also consider proposals for fund raising, with the mode of raising funds yet to be ascertained.
Apr 28 2026 16:04:00

Wockhardt Limited

Wockhardt board meeting scheduled for May 4, 2026, to approve audited annual standalone and consolidated financial results for FY26. The board will also consider proposals for fund raising, with the mode of raising funds yet to be ascertained.
Apr 28 2026 15:04:00
Read More

About Wockhardt

NSE : 7506  
BSE : 532300  
ISIN : INE049B01025  

Wockhardt Management

NamePosition
Rashmi MamturaCompany Secretary & Compliance Officer
Habil KhorakiwalaChairman
View More

Wockhardt FAQs

The Buying Price of Wockhardt share is 1716.9 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

To buy Wockhardt stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Wockhardt, choose your preferred order type, and place the trade.

The Price-to-earnings (P/E) ratio of Wockhardt shares is 117.27. You can compare it with the sector average for relative valuation.

The Price to Book (P/B) ratio Wockhardt shares is 5.06. Useful to assess the stock's value relative to its book value.

To assess Wockhardt’s valuation compare Sector P/E, P/B which are 65.98 & 3.52 with sector averages, along with growth rates and financial metrics.

The Market Cap of Wockhardt is 27898.28 CR. It indicates the company's size category and trading liquidity.

The 52 week high and low prices of Wockhardt share price is 1868.80 & 1086.70. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.

Wockhardt belongs to the Healthcare sector.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost